To: henry jakala who wrote (6587 ) 9/9/1998 4:24:00 PM From: X-Ray Man Read Replies (2) | Respond to of 9695
Maybe. But let's look at this fresh. Check the balance sheet. Check the earnings. This is still essentially a venture play. So, a venture play that is currently earning 10c/y with alot of pans in the fire and been able to keep themselves afloat certainly should command a p/e of 20, no? What I think we are seeing is capitulation of those who invested earlier at much higher levels and have lost patience waiting for a payoff. That doesn't mean this still can't be a good play for those entering today. I honestly don't know if JMAR is the company to bring XRL into commerce. But just on that play alone, I think it is worth $2, since I know that if point-source XRL comes on line it will be with JMAR first, and I know that XRL is going to be a needed tool, since I have less faith in SCALPEL or XUV. Time frame, in my mind, is still another year or two out. Meanwhile, JMAR has the potential to grow their aquired businesses and hopefully grow earnings as well. Consider, if JMAR for the next year can post earnings of 0.15c/y, that would suggest a p/e of as much as 50 could be justified, or a valuation $4.50. So, that is my 1 year target, and why entering at or under $2 seems very attractive, especially when you add the more speculative new technologies. The legitimate counterpoint, especially from those who have been with this stock for a while, is that management has not yet delivered on any of their promises for the new technology. This may well be true. But in the meantime, they have kept the company afloat, aquired some lines, and are slowly building a presence in the industry. As long as their accounting is on the up-and-up, this should still be an interesting stock to follow. JMO